Oct 23, 2017 | Class Action Lawsuit, Defective Drugs, Defective Products, Diabetes, Drug Side Effects, Heart Attack Risk, Mass Tort, Pharmaceutical Litigation, Product Liability, Wrongful Death Cases
A motion was filed on October 11, 2017, by one of the persons suing Bristol-Myers Squibb Company and other defendants to transfer and consolidate all Onglyza® and Kombiglyze® cases into an MDL (multidistrict litigation) in the Northern District of California. The...
Feb 3, 2016 | Class Action Lawsuit, Diabetes, Drug Side Effects, Heart Attack Risk, Injury Lawyer, Personal Injury, Pharmaceutical Litigation
What is Onglyza? Onglyza and Kombiglyze XR are used by Type 2 diabetic patients to help lower blood sugar (glucose) levels. Both are known by their generic name Saxagliptin, which is classified as a dipeptidyl pepidase-4 (DPP-4) inhibitor. The drug was approved by the...
Aug 6, 2015 | Defective Drugs, Diabetes, Drug Side Effects, Heart Attack Risk, Pharmaceutical Litigation
Type 2 Diabetics At Risk of Heart Failure While Taking Onglyza or Kombiglyze XR Type 2 Diabetes medications typically carry dangerous side effects. So much so, that the U.S. Food & Drug Administration (FDA) formally requested that drug manufacturers any Type 2...
